MENU
BNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioNTech SE American Depositary Share (BNTX) Ownership - Who owns BioNTech SE American Depositary Share?

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid... Show more

Profile

Industry
N/A
Address
An der Goldgrube 12
Phone
+49 613190840
Employees
6133
Web
https://www.biontech.de

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.85B
P/E Ratio
161.76
Total Cash
14.52B
Projected Growth
N/A
Total Debt
245.4M
Revenue
3.15B
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash/Share
60.38
Total Debt/Equity
N/A
Revenue/Share
15.49 USD as % of share price

Fundamentals

BNTX
Capitalization
22.9B
P/E Ratio
161.76
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash
14.5B
Total Cash/Share
60.38
Total Debt
245M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
15.49%
Revenue
3.15B
ROE
N/A
Book Value
18.5B
P/B Ratio
1.05
Cash Flow
N/A
Earnings
-2.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
249M
Current Ratio
7.12
Current Revenue Per Employee
224291.20
Dividends Per Share - Security
N/A
EBITDA
171M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.24
Revenue To Assets
-2.61
Shares Held By Institutions
10.7B
Shares Outstanding - Current
240M
Total Liabilities
2.86B
Total Volume MTD
N/A
Value
-1
Gain YTD
-16.604
View a ticker or compare two or three
BNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BNTX showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
An der Goldgrube 12
Phone
+49 613190840
Employees
6133
Web
https://www.biontech.de